IL-37 dampens immunosuppressive functions of MDSCs via metabolic reprogramming in the tumor microenvironment
Open Access
- 26 February 2024
- journal article
- research article
- Published by Elsevier in Cell Reports
- Vol. 43 (3) , 113835
Abstract
No abstract availableKeywords
Funding Information
- National Research Foundation of Singapore
- Government of Singapore Ministry of Education
This publication has 55 references indexed in Scilit:
- The indirect antiangiogenic effect of IL-37 in the tumor microenvironmentJournal of Leukocyte Biology, 2020
- NCR− group 3 innate lymphoid cells orchestrate IL-23/IL-17 axis to promote hepatocellular carcinoma developmentEBioMedicine, 2019
- IL‐37: An anti‐inflammatory cytokine with antitumor functionsCancer Reports, 2018
- Tumor Microenvironment Heterogeneity: Challenges and OpportunitiesCurrent Molecular Biology Reports, 2017
- IL-37 mediates the antitumor activity in renal cell carcinomaMedical Oncology, 2015
- Interleukin-22 promotes human hepatocellular carcinoma by activation of STAT3Hepatology, 2011
- Tumor-Induced Tolerance and Immune Suppression Depend on the C/EBPβ Transcription FactorImmunity, 2010
- The immunosuppressive tumor microenvironment in hepatocellular carcinomaCancer Immunology, Immunotherapy, 2008
- IL-1H, AN INTERLEUKIN 1-RELATED PROTEIN THAT BINDS IL-18 RECEPTOR/IL-1RrpCytokine, 2001
- Identification and Gene Organization of Three Novel Members of the IL-1 Family on Human Chromosome 2Genomics, 2000